Recent Finacing
Recent Raise
Anticancer Bioscience develops targeted oncology small-molecule therapeutics using synthetic‑lethal strategies and proprietary screening platforms, leveraging a large natural‑product and scaffold library across multiple preclinical programs (MYC, polyploid, contact‑inhibition, centrosome).
